Kyoung-Ho Pyo

9PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 05, 2024
Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab.

Dong Kwon Kim, Chun-Bong Synn, Wongeun Lee

|Nov 28, 2024
Mutation-Driven Immune Microenvironments in Non-Small Cell Lung Cancer: Unrevealing Patterns through Cluster Analysis.

Youngtaek Kim, Joon Yeon Hwang, Kwangmin Na

|Aug 28, 2024
Exploring the Expression and Function of T Cell Surface Markers Identified through Cellular Indexing of Transcriptomes and Epitopes by Sequencing.

Joon Yeon Hwang, Youngtaek Kim, Kwangmin Na

|Jun 25, 2024
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.

Sun M Lim, Seong-San Kang, Dong K Kim

|Sep 28, 2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies.

Youngtaek Kim, Joon Yeon Hwang, Dong Kwon Kim

|Jan 10, 2022
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models.

Chun-Bong Synn, Sung Eun Kim, Hee Kyu Lee

Pageof 2

Frequent Collaborators

7 joint publications

Min Hee Hong

7 joint publications

Dong Kwon Kim

6 joint publications

Seok-Young Kim

5 joint publications

Youngtaek Kim